4.8 Article

Carbon nanotubes' surface chemistry determines their potency as vaccine nanocarriers in vitro and in vivo

Journal

JOURNAL OF CONTROLLED RELEASE
Volume 225, Issue -, Pages 205-216

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jconrel.2016.01.030

Keywords

Vaccine delivery; Carbon nanotubes; Dendritic cells; Nanomedicine

Funding

  1. Biotechnology and Biological Sciences Research Council [BB/J008656/1]
  2. Worldwide Cancer Research [12-1054]
  3. EU FP7-ITN Marie-Curie Network programme RADDEL [290023]
  4. COST Action [TD1004]
  5. YCCF
  6. BHF Programme Grant [RG13/12/30395]
  7. Biotechnology and Biological Sciences Research Council [BB/J008656/1] Funding Source: researchfish
  8. Medical Research Council [MR/J006742/1] Funding Source: researchfish
  9. Worldwide Cancer Research [12-1054] Funding Source: researchfish
  10. BBSRC [BB/J008656/1] Funding Source: UKRI

Ask authors/readers for more resources

Carbon nanotubes (CNTs) have shown marked capabilities in enhancing antigen delivery to antigen presenting cells. However, proper understanding of how altering the physical properties of CNTs may influence antigen uptake by antigen presenting cells, such as dendritic cells (DCs), has not been established yet. We hypothesized that altering the physical properties of multi-walled CNTs (MWNTs)-antigen conjugates, e.g. length and surface charge, can affect the internalization of MWNT-antigen by DCs, hence the induced immune response potency. For this purpose, pristine MWNTs (p-MWNTs) were exposed to various chemical reactions to modify their physical properties then conjugated to ovalbumin (OVA), a model antigen. The yielded MWNTs-OVA conjugates were long MWNT-OVA (similar to 386 nm), bearing net positive charge (5.8 mV), or short MWNTs-OVA (similar to 122 nm) of increasing negative charges (-23.4, -35.8 or -39 mV). Compared to the short MWNTs-OVA bearing high negative charges, short MWNT-OVA with the lowest negative charge demonstrated better cellular uptake and OVA-specific immune response both in vitro and in vivo. However, long positively-charged MWNT-OVA showed limited cellular uptake and OVA specific immune response in contrast to short MWNT-OVA displaying the least negative charge. We suggest that reduction in charge negativity of MWNT-antigen conjugate enhances cellular uptake and thus the elicited immune response intensity. Nevertheless, length of MWNT-antigen conjugate might also affect the cellular uptake and immune response potency; highlighting the importance of physical properties as a consideration in designing a MWNT-based vaccine delivery system. (C) 2016 The Authors. Published by Elsevier B.V.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available